Department of Vitreoretina, Medical Research Foundations, Sankara Nethralaya, Sankara Nethralaya, Chennai, Tamil Nadu, India.
Uvea, Medical Research Foundations, Sankara Nethralaya, Sankara Nethralaya, Chennai, Tamil Nadu, India.
Indian J Ophthalmol. 2022 Oct;70(10):3713-3715. doi: 10.4103/ijo.IJO_1927_22.
A 13-year-old boy developed painless diminution of vision in left eye 15 days after taking first dose of coronavirus disease 2019 (COVID-19) vaccine (Corbevax). Fundus and fluorescein angiography revealed central retinal vein occlusion in the left eye. Blood investigations were noncontributory. He was administered three doses of pulse corticosteroids followed by a tapering dose of oral corticosteroids. Retinal vascular occlusion can occur following COVID-19 vaccination in children, and early and aggressive systemic anti-inflammatory therapy can be helpful.
一名 13 岁男孩在接种第一剂 2019 冠状病毒病（COVID-19）疫苗（Corbevax）后 15 天出现左眼无痛性视力减退。眼底和荧光素血管造影显示左眼视网膜中央静脉阻塞。血液检查无异常。他接受了三剂脉冲糖皮质激素治疗，随后逐渐减少口服糖皮质激素剂量。儿童在接种 COVID-19 疫苗后可能会发生视网膜血管阻塞，早期和积极的全身抗炎治疗可能会有所帮助。
